Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$3,321 Mln
Revenue (TTM)
$2,402 Mln
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
39.3
P/B Ratio
2.7
Industry P/E
36.82
EV/EBITDA
14.4
Div. Yield
0 %
Debt to Equity
0.3
Book Value
$--
EPS
$4.5
Face value
--
Shares outstanding
32,887,700
CFO
$1,384.04 Mln
EBITDA
$1,909.80 Mln
Net Profit
$825.04 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Amedisys (AMED)
| 11.2 | 3.3 | 6.9 | 3.2 | -6.2 | -15.2 | 8.3 |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Amedisys (AMED)
| -4.5 | 13.8 | -48.4 | -44.8 | 75.7 | 42.5 | 121.2 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of... patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was formerly known as Analytical Nursing Management Corp. and changed its name to Amedisys, Inc. in August 1995. The company was founded in 1982 and is headquartered in Baton Rouge, Louisiana with an additional office in Nashville, Tennessee. As of August 14, 2025, Amedisys, Inc. operates as a subsidiary of Optum, Inc. Read more
Executive VP, COO, CFO & Principal Financial Officer
Mr. Scott G. Ginn
Executive VP, COO, CFO & Principal Financial Officer
Mr. Scott G. Ginn
Headquarters
Baton Rouge, LA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Amedisys Inc (AMED) is $100.99 (NASDAQ) as of 15-Aug-2025 09:30 EDT. Amedisys Inc (AMED) has given a return of -6.2% in the last 3 years.
The P/E ratio of Amedisys Inc (AMED) is 39.30 times as on 15-Aug-2025, a 7 premium to its peers’ median range of 36.82 times.
The P/B ratio of Amedisys Inc (AMED) is 2.69 times as on 15-Aug-2025, a 19 discount to its peers’ median range of 3.32 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
68.71
|
2.62
|
|
2023
|
-320.99
|
2.93
|
|
2022
|
22.96
|
2.59
|
|
2021
|
25.41
|
5.71
|
|
2020
|
53.11
|
12.05
|
The 52-week high and low of Amedisys Inc (AMED) are Rs 101.02 and Rs 82.15 as of 03-Apr-2026.
Amedisys Inc (AMED) has a market capitalisation of $ 3,321 Mln as on 15-Aug-2025. As per SEBI classification, it is a Small Cap company.
Before investing in Amedisys Inc (AMED), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.